N/A
N=22
Effects of Acute Intermittent Hypoxia on Sensory Function in Healthy Adults
Sensitivity
Bottom Line
View on ClinicalTrials.gov: NCT03283072 ↗Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcome: Primary: Sensory Function — 46.7; 46.4; 46.1; 45.9 Degrees celsius — p=0.592
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Intervention 1 (Device); Intervention 2 (Device); Intervention 3 (Device); Intervention 4 (sham) (Device)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Florida
- Primary completion
- Jul 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Sensory Function |
46.7; 46.4; 46.1; 45.9 | 0.592 |
| PRIMARY Temporal Sensory Summation |
17.4; 11.7; 10.9; 11.9 | 0.721 |
| PRIMARY Sensory Function - Pressure |
4.4; 4.6; 4.3; 4.3 | 0.553 |
Summary
Exposure to acute intermittent hypoxia (AIH) can facilitate of motor output but no studies of sensory effects has been reported.
Eligibility Criteria
Inclusion Criteria
- 18 to 40 years of age
Exclusion Criteria
- Diagnosis of cardiovascular disease (Hypertension, arrhythmias, coronary artery disease, congenital and valvar heart diseases)
- Diagnosis of neuromuscular disease
- Diagnosis of any neurological disease
- Presence of concurrent medical illness including infection, fractures
- Diagnosis of obstructive sleep apnea
- Diagnosis of obstructive/restrictive lung disease
- Diagnosis of exercise induced asthma
- FEV1/FVC 35kg/m2
- Subjects on prescription medicines such as beta blockers and other drugs that are prescribed in any of the exclusionary disorders listed above.
Data sourced from ClinicalTrials.gov (NCT03283072). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.